James Huang - Jun 7, 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
Director
Signature
/s/ John P. Hamill, as Attorney-in-Fact
Stock symbol
WINT
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/9/2022, 08:16 PM
Previous filing
May 26, 2022
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WINT Common Stock Award $0 +5K +1.72% $0.00 296K Jun 7, 2022 Direct F1
holding WINT Common Stock 2.34M Jun 7, 2022 Via Panacea Venture Healthcare Fund I L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WINT Stock Option (Right to Buy) Award $0 +7.5K $0.00 7.5K Jun 7, 2022 Common Stock 7.5K $0.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.
F2 The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.
F3 The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.